Market Closed -
Nyse
04:00:02 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
7.79
USD
|
-5.00%
|
|
-4.65%
|
-16.24%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,306
|
2,058
|
2,319
|
1,217
|
770.3
|
644.9
|
-
|
-
|
Enterprise Value (EV)
1 |
3,924
|
2,679
|
2,937
|
1,859
|
1,330
|
1,071
|
943
|
813.9
|
P/E ratio
|
-1.55
x
|
-2.57
x
|
17.8
x
|
18.8
x
|
-12.7
x
|
8.63
x
|
7.71
x
|
8.24
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.66
x
|
1.19
x
|
1.21
x
|
0.62
x
|
0.39
x
|
0.32
x
|
0.31
x
|
0.3
x
|
EV / Revenue
|
1.12
x
|
1.55
x
|
1.54
x
|
0.94
x
|
0.67
x
|
0.53
x
|
0.45
x
|
0.38
x
|
EV / EBITDA
|
7.84
x
|
12.2
x
|
11.1
x
|
7.71
x
|
6.64
x
|
5.32
x
|
4.52
x
|
3.8
x
|
EV / FCF
|
12.5
x
|
15.2
x
|
66
x
|
-
|
12.8
x
|
10.4
x
|
8.72
x
|
-
|
FCF Yield
|
8.02%
|
6.56%
|
1.51%
|
-
|
7.82%
|
9.62%
|
11.5%
|
-
|
Price to Book
|
1.56
x
|
2.81
x
|
2.62
x
|
1.38
x
|
0.92
x
|
0.7
x
|
0.64
x
|
0.59
x
|
Nbr of stocks (in thousands)
|
82,988
|
83,875
|
85,241
|
81,926
|
82,829
|
82,790
|
-
|
-
|
Reference price
2 |
27.79
|
24.54
|
27.21
|
14.86
|
9.300
|
7.790
|
7.790
|
7.790
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/17/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,514
|
1,734
|
1,911
|
1,972
|
1,995
|
2,021
|
2,077
|
2,148
|
EBITDA
1 |
500.8
|
219.9
|
265.5
|
241
|
200.4
|
201.3
|
208.4
|
214.3
|
EBIT
1 |
408.5
|
191.4
|
233.3
|
205.4
|
164.2
|
163.6
|
171.8
|
180.8
|
Operating Margin
|
11.63%
|
11.04%
|
12.21%
|
10.42%
|
8.23%
|
8.09%
|
8.27%
|
8.41%
|
Earnings before Tax (EBT)
1 |
-1,242
|
7.148
|
135.2
|
81.37
|
-48.36
|
112
|
125.9
|
129.1
|
Net income
1 |
-1,498
|
-796.5
|
131
|
66.34
|
-60.41
|
74.29
|
83.01
|
60.1
|
Net margin
|
-42.63%
|
-45.93%
|
6.85%
|
3.36%
|
-3.03%
|
3.68%
|
4%
|
2.8%
|
EPS
2 |
-17.94
|
-9.550
|
1.530
|
0.7900
|
-0.7300
|
0.9025
|
1.010
|
0.9450
|
Free Cash Flow
1 |
314.8
|
175.8
|
44.49
|
-
|
104
|
103
|
108.1
|
-
|
FCF margin
|
8.96%
|
10.14%
|
2.33%
|
-
|
5.21%
|
5.1%
|
5.2%
|
-
|
FCF Conversion (EBITDA)
|
62.85%
|
79.97%
|
16.76%
|
-
|
51.89%
|
51.18%
|
51.87%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
33.97%
|
-
|
-
|
138.69%
|
130.22%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/17/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
498.5
|
482.2
|
486
|
489.9
|
513.8
|
491
|
500.6
|
506.6
|
496.4
|
495.1
|
505.3
|
512.8
|
507.8
|
508.2
|
515.7
|
EBITDA
1 |
81.04
|
50.68
|
65.56
|
58.31
|
66.49
|
40.06
|
59.12
|
50.42
|
50.82
|
37.21
|
51.07
|
56.69
|
56.89
|
38.34
|
52.66
|
EBIT
1 |
73.18
|
41.91
|
56.78
|
49.35
|
57.35
|
31.1
|
50.18
|
40.27
|
41.76
|
26.9
|
40.96
|
48.95
|
47.04
|
27.15
|
43.74
|
Operating Margin
|
14.68%
|
8.69%
|
11.68%
|
10.07%
|
11.16%
|
6.33%
|
10.02%
|
7.95%
|
8.41%
|
5.43%
|
8.11%
|
9.55%
|
9.26%
|
5.34%
|
8.48%
|
Earnings before Tax (EBT)
1 |
53.52
|
-28.35
|
43.03
|
38.86
|
27.82
|
20.71
|
38.95
|
30.83
|
-138.8
|
7.824
|
29.23
|
37.04
|
37.93
|
19.44
|
32.62
|
Net income
1 |
47.52
|
-21.19
|
27.14
|
30.73
|
29.66
|
14.21
|
28.28
|
21.39
|
-124.3
|
4.035
|
20.16
|
22.57
|
24.06
|
10.94
|
19.8
|
Net margin
|
9.53%
|
-4.39%
|
5.58%
|
6.27%
|
5.77%
|
2.89%
|
5.65%
|
4.22%
|
-25.04%
|
0.81%
|
3.99%
|
4.4%
|
4.74%
|
2.15%
|
3.84%
|
EPS
2 |
0.5500
|
-0.2500
|
0.3200
|
0.3700
|
0.3600
|
0.1700
|
0.3400
|
0.2600
|
-1.500
|
0.0500
|
0.2425
|
0.2725
|
0.2925
|
0.1333
|
0.2350
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/22
|
4/28/22
|
8/4/22
|
11/3/22
|
2/17/23
|
5/2/23
|
8/3/23
|
11/2/23
|
2/20/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,618
|
621
|
617
|
641
|
560
|
426
|
298
|
169
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.23
x
|
2.824
x
|
2.325
x
|
2.661
x
|
2.795
x
|
2.115
x
|
1.43
x
|
0.7884
x
|
Free Cash Flow
1 |
315
|
176
|
44.5
|
-
|
104
|
103
|
108
|
-
|
ROE (net income / shareholders' equity)
|
12.3%
|
7.04%
|
15.9%
|
15.7%
|
11.9%
|
11.3%
|
11.7%
|
10.9%
|
ROA (Net income/ Total Assets)
|
5.6%
|
2.11%
|
7.08%
|
5.52%
|
4.54%
|
4.65%
|
5.14%
|
5.33%
|
Assets
1 |
-26,758
|
-37,759
|
1,850
|
1,202
|
-1,332
|
1,598
|
1,614
|
1,128
|
Book Value Per Share
2 |
17.80
|
8.730
|
10.40
|
10.70
|
10.10
|
11.20
|
12.20
|
13.30
|
Cash Flow per Share
2 |
4.150
|
2.450
|
0.8900
|
-
|
1.670
|
1.350
|
1.880
|
2.080
|
Capex
1 |
31.9
|
28.8
|
32.2
|
-
|
33.3
|
26.2
|
29.6
|
28.8
|
Capex / Sales
|
0.91%
|
1.66%
|
1.69%
|
-
|
1.67%
|
1.3%
|
1.43%
|
1.34%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/17/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
7.79
USD Average target price
9
USD Spread / Average Target +15.53% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.24% | 679M | | +19.22% | 85.64B | | -27.14% | 70.63B | | +4.65% | 27.05B | | -6.23% | 17.97B | | +1.60% | 17.58B | | +3.30% | 15.64B | | +7.44% | 13.55B | | +9.91% | 13.41B | | +73.32% | 13.18B |
Other Healthcare Facilities & Services
|